Anticancer Effect of Aqueous and Ethanol Extract of Pepperfruit (Dennettia tripetala) fruit on MCF-7 Breast Cancer Cell Line using Neutral Red Uptake Assay

Sarah I David; Barnabas Danborno; Zainab Bauchi

doi:10.55006/biolsciences.2024.4402

Authors

Sarah I David Department of Anatomy, Faculty of Basic Medical Sciences, College of Medicine and Allied Health Sciences, Bingham University, Karu, Nasarawa State, Nigeria https://orcid.org/0000-0001-7234-6818
Barnabas Danborno Department of Anatomy, Faculty of Basic Medical Sciences, College of Medical Sciences, Ahmadu Bello University, Zaria, Nigeria https://orcid.org/0000-0001-5681-2575
Zainab Bauchi Department of Anatomy, Faculty of Basic Medical Sciences, College of Medical Sciences, Abubakar Tafawa Balewa University, Bauchi, Nigeria. https://orcid.org/0000-0002-1109-4378

DOI:

https://doi.org/10.55006/biolsciences.2024.4402

Keywords:

Dennettia tripetala, Cytotoxicity, Half Inhibitory Concentration, MCF-7 cell lines, Neutral red uptake

Abstract

Breast cancer is the second leading cause of death in women. Natural products from plants and microorganism have provided the main source of folk medicine with a larger percentage of prescribed drugs containing compounds derived from plants, some being of great significance to cancer therapy. The significance of the study was to provide additional information on the potency of Dennettia tripetala against cancer. The study was aimed at evaluating the anticancer activity of aqueous and ethanol extract of Dennettia tripetala fruit against MCF-7 cell lines. About 150 g of the pulverized plant fruit was soaked in 1.5 litres of distilled water and alcohol to obtain aqueous and ethanol extracts. The extracts were concentrated to 3.125, 6.25, 12.5,25.0 and 50.0 µg/ml and used for experiment. Phytochemical analysis indicated presence of glycoside, saponins, steroids and triterpenes in the aqueous extract. All were present in the ethanol extract including tannins and excluding saponins. MCF-7 cell was cultured and then subcultured at confluence before treating with 5-fluorouracil drug as positive control, dimethyl sulfoxide as negative control and the various extracts of aqueous and ethanol extracts of Dennettia tripetala. The cytotoxicity assay was determined using neutral red uptake assay after 72 hours of treatment and the half inhibitory concentration was obtained from the linear regression equation after plotting a dose response curve of percentage cell inhibition. The result obtained from the cytotoxicity assay showed statistically significant increase (P<0.05) for percentage cell inhibition by the aqueous and ethanol extracts of Dennettia tripetala against the MCF-7 cell line at 25.0 and 50.0 µg/ml. The half inhibitory concentration was 37.42 and 61.74 µg/ml for aqueous and ethanol extract respectively. In conclusion, there is anticancer potency of Dennettia tripetala fruit against MCF-7 cancer cell line.

Downloads

Download data is not yet available.

References

1. Jemal A, Siegel R, Ward E, Murray T, Jiaquan X, Thun MJ. Cancer Statistics. CA: A Cancer Journal for Clinicians. 2007; 5(1): 43-66

2. Nahata, A. Anticancer Agents: A review of relevant information on important herbal drugs. International Journal of Clinical Pharmacology and Toxicology (IJCPT). 2017; 6(2): 250-255.

3. Erhabor O, Abdulrahaman RM, Forget P, Vaidya J, Bello O, Adias TC, Dagana A, Egenti BN, Mainasara AS, Sahabi SM, Rilwanu TI, Ahmed Y, Hassan M, Ajayi OI, Okara GC, Lori J. and Ibiang L. Breast cancer in Nigeria: diagnosis, management and challenges. Bloomington: AuthorHouse; 2016, pp 2.

4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. 2010; 127: 2893–2917.

5. Sylla BS and Wild CP. A million Africans a year dying from cancer by 2030: What can cancer research and control offer to the continent? International Journal of Cancer. 2011; 130(2): 245-50.

6. Akarolo-Anthony SN, Ogundiran TO and Adebamowo CA. Emerging breast cancer epidemic: Evidence from Africa. Breast Cancer Research. 2010; 12: S4-S8.

7. Newman DJ, Cragg GM and Snader KM. Natural products as sources of new drugs over the period 1981-2002. Journal of Natural Products. 2003; 66(7): 1022-1037.

8. World Health Organisation. Traditional medicine fact sheet. Geneva: WHO. 2008.

9. Desai GA, Qazi NG, Ganju KR, El-Tamer M, Singh J, Saxena KA, Bedi SB, Taneja CS and Bhat KH. Medicinal Plants and Cancer Chemoprevention. Current Drug Metabolism. 2008; 9(7): 581–591.

10. Jagla SW. Effects of seed extracts from traditional Nigerian medical plants on prostate cancer cell growth (M. Sc Thesis, University of Illinois, Chicago). 2013.

11. Shi M, Cai Q, Yao L, Mao Y, Ming Y and Ouyang G. Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biology International. 2006; 30(3): 221-226.

12. Etukudo I. Forest, our divine treasure. Uyo: Dorland Publisher; 2000, pp. 24.

13. Iseghohi OS. A review of the uses and medicinal properties of Dennettia tripetala (Pepperfruit). Medical Sciences. 2015; 3(4): 104-111.

14. Iwu MM. Food for medicine. In Iwu M. (Ed.), Dietary plants and masticators as sources of biologically active substances. Ile Ife: Univ. Ife Press; 1989, pp. 303-310.

15. Umoh IB. Commonly used fruits in Nigeria. In Osagie A. and Eka, O. A. (Eds.), Nutritional quality of plant foods. Benin: Postharvest Research Unit University of Benin; 1998, pp. 256-262.

16. Okwu ED, Morah NIF and Anam EM. Isolation and characterization of Phenanthrenic alkaloid uvariopsine from Dennettia tripetala fruits. Journal of Medicinal and Aromatic Plant Sciences. 2005; 27: 496-498.

17. Ihemeje A, Ojinnaka MC, Obi KC and Ekwe CC. Biochemical evaluation of Pepperfruit (Dennettia tripetala) and its use as substitute for ginger in zobo drink production. Academic Research International. 2013; 4(6): 513–521.

18. Adedayo BC, Oboh G and Akindahunsi AA. Changes in the total phenol content and antioxidant properties of pepperfruit (Dennettia tripetala) with ripening. African Journal of Food Science. 2010; 4(6): 403–409.

19. Bassey UE, Akpakpan EI, Etim OE, Akaka EUA and Ekanemesang UM. Effect of ethanol extract of ripe fruits of Dennettia tripetala on prostatic and testicular functions of male albino rats. The Journal of Medical Research. 2018; 4(2): 89-92. ISSN: 2395- 7565.

20. Ejechi BO and Akpomedaye DE. Activity of essential oil and phenolic acid extracts of pepperfruit (Dennettia tripetala G. Barker; Anonancea) against some food-borne microrganisms. African Journal of Biotechnology. 2005; 4(2): 258-261.

21. Oyemitan IA, Iwalewa EO, Akanmu MA and Olugbada TA. Antinocieptive and anti- inflammatory effect of essential oil of Dennettia tripetala G. Baker (Annonacae) in Rodent. African Journal of Traditional Complementary and Alternative Medicine. 2008; 5(4): 355-362.

22. Akinwumi FO. Evaluation of some plant materials for the control of smoked fish pest, Dermestes maculatus degeer (Coleoptera: Dermestidae) in Clarias gariepinus Burchell (Pisces: Clariidae). ARPN: Journal of Agricultural and Biological Science. 2011; 6(7): 65-69.

23. Ikpi DE and Nku O. Effect of ethanolic extract of Dennettia tripetala fruit on haematological parameters in albino wistar rats. Nigerian Journal of Physiological Sciences. 2008; 23: 13–17.

24. Nwosu CL, Adedire OC, Ogunwolu OE and Ashamo OM. Toxicological and histopathological effects of Dennettia tripetala seed used as grain protectant, food, and medicine. Food Quality and Safety. 2017; 1(3): 211–220.

25. Ejechi BO, Nwafor OE and Okoko FJ. Growth inhibition of tomato-rot fungi by phenolic acids and essential oil extracts of pepperfruit. Food Research International. 1999; 32 (6): 395–399.

26. Anyaele OO and Amusan AAS. Toxicity of hexanolic extract of Dennettia tripetala (G. Baker) on larvae of Aedes aegypti (l). African Journal of Biomedical Research. 2003; 6: 49–53.

27. Nwachukwu E and Osuji J. Evaluation of plant extracts for antifungal activity against Sclerotiumrolfsii causing cocoyam cormel rot in storage. Research Journal of Agriculture and Biological Sciences. 2008; 6: 784–787.

28. Anaga AO and Asuzu IU. Antihyperglycaemic properties of the ethyl acetate extract of Dennettia tripetala in diabetic rats. Journal of Complementary and Integrative Medicine. 2010.

29. Aderogba MA, Akinkunmi EO and Mabusela WT. Antioxidant and antimicrobial activities of flavonoid glycosides from Dennettia tripetala G. Baker Leaf Extract. Nigerian Journal of Natural Products and Medicine. 2011; 15: 49–52.

30. Okolie NP, Falodun A and Davids O. Evaluation of the antioxidant activity of the root extract of Pepperfruit (Dennettia tripetala) and its potential for the inhibition of lipid peroxidation. African Journal of Traditional Complementary Alternative Medicine. 2014; 11(3): 221–227.

31. Okwu ED and Morah NIF. Mineral and nutritive value of Dennettia tripetala fruits. Fruits. 2004; 59: 437–442.

32. Elekwa I, Okereke SC and Chukwudomo CS. Phytochemical screening and GC-MS analysis of the essential oil of Dennettia tripetala (Pepperfruit) seeds. ABSU Journal of Environment, Science and Technology. 2011; 1: 93–98.

33. Neuhouser ML. Dietary flavonoids and cancer risk: evidence from human population studies. Nutriton and Cancer. 2004; 50(1): 1–7.

34. Graf BA, Milbury PE and Blumberg JB. Flavonoids, flavones and human health: epidemiological evidence. Journal of Medicinal Food. 2005; 8(3): 281–290.

35. Koralek DO, Peters U and Andriole GA. Prospective study of dietary α-linoleic acid and the risk of prostate cancer. Cancer Causes and Control. 2006; 17: 783–791.

36. Rohin KAM, Ridzwan N, Jumli NM, Hadi AN, Johari TTAS and Latif AZA. Cytotoxicity study and morphological changes of different extraction for Bismillah leaf (Vernonia amygdalina) in human glioblastoma multiforme cell line (U-87). Biomedical Research. 2017; 28(4): 1472-1478.

37. Trease G and Evans WC. Pharmacognosy, 13th ed. Saunders English Language Book Society. Bailliere Tindall, Britain, 1989; 153-157.

38. Shuaibu K. Anthelmintic efficacy of crude methanol extract of Dennettia tripetala g. Baker fruits with its various chemical fractions in mice experimentally infected with heligmosomoides bakeri. (M.Sc Thesis, Ahmadu Bello University, Zaria). 2015.

39. Ramya N, Priyadharshini PR and Dhivya R. Anticancer activity of Trachyspermum ammi against MCF7 cell lines mediates by p53 and Bcl-2 mRNA levels. The Journal of Phytopharmacology. 2017; 6(2): 78-83.

40. Repetto G, del Peso A. and Zurita LJ. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. National Institute of Toxicology and Forensic Sciences. 2008; 3:1125-1131.

41. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA: A Cancer Journal for Clinicians. 2011; 61(2): 69-90.

42. Ponce-Cusi R and Calaf MG. Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing alpha-pacticle radiation. International Journal of Oncology. 2015: 774-782.

43. Weatherbee DS, Grenier KJ and Carrol BS. DNA to Diversity: Molecular Genetics and the Evolution of Animal Design, 2nd ed. Blackwell, Oxford; 2001, pp 214.

44. Gaffield ME, Culwell KR and Ravi A. Oral contraceptives and family history of breast cancer. Contraception. 2009; 80(4): 372–380.

45. Duncan JA, Reeves JR and Cooke TG. BRCA1, and BRCA2 proteins: roles in health and disease. Molecular Pathology. 1998; 51(5): 237–247.

46. Hosseinzadeh E, Banaee N and Nedaie AH. Cancer and treatment modalities. Current Cancer Therapy Reviews. 2017; 13(1): 17-27.

47. Abbas Z and Rehman S. An overview of cancer treatment modalities: In, Neoplasm. 2018: 139-157.

48. Senapati S, Mahanta KA, Kumar S and Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduction and Targeted Therapy. 2018; 3: 7.

49. Chow LWC and Loo WTY. The differential effects of cyclophosphamide, epirubicin and 5-fluorouracil on apoptotic marker (CPP-32), pro-apoptotic protein (p21 WAF-1) and anti-apoptotic protein (bcl-2) in breast cancer cells. Breast Cancer Research and Treatment. 2003; 80: 239-244.

50. Longley DB, Harkin DP and Johnston PG. 5-Fluorouracil: Mechanism of action and clinical strategies. Nature Reviews Cancer. 2003; 3: 330-338.

51. Pal S, Sarkar A, Pal PB and Sil PC. Protective effect of arjunolic acid against atorvastatin induced hepatic and renal pathophysiology via MAPK, mitochondria and dependent pathways. Biochimie. 2015; 112: 20–34.

52. Dutta S, Saha, S, Mahalanobish S, Sadhukhan P and Sil PC. Melatonin attenuates arsenic-induced nephropathy via the regulation of oxidative stress and inflammatory signaling cascades in mice. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association. 2018; 118: 303– 316.

53. Sadhukhan P, Saha S, Dutta S, Mahalanobish S and Sil PC. Nutraceuticals: an emerging therapeutic approach against the pathogenesis of Alzheimer's disease. Pharmacological Research. 2018; 129: 100–114.

54. Sawadogo WR, Schumacher M, Teiten MH, Dicato M and Diederich M. Traditional West African Pharmacopeia, plants and derived compounds for cancer therapy. Biochemical Pharmacology. 2012; 84(10): 1225-1240.

55. Chudzik M, Kornonek-Szlacheta H and Krol W. Triterpenes as potentially cytotoxic compounds. Molecules. 2015; 20: 1610-1625.

56. Khan H, Saeedi M, Nabavi MS, Mubarak SM and Bishayee A. Glycosides from medicinal plants as potential anticancer agents: Emerging trends towards future drugs. Current Medicinal Chemistry. 2019; 26(13): 2389-2406.

57. Egharevba HO and Idah EA. Major compounds from the essential oil of the fruit and comparative phytochemical studies of the fruits and leaves of Dennettia tripetala Barker F. Found in North Central Nigeria. International Journal of Pharmacognosy and Phytochemical Research. 2015; 7(6): 1262-1266.

58. Omage OS, Orhue EJN and Omage K. Evaluation of the phytochemical content, in vitro antioxidant capacity, biochemical and histological effects of Dennettia tripetala fruits in healthy rats. Food Science and Nutrition. 2019; 7(1): 65-75.

59. Andola CH, Gaira SK, Rawal SR, Rawat MSM and Bhatt DI. Habitat-dependent variations in berberine content of Berberis asiatica Roxb. ex. DC. in Kumaon western Himalaya. Chemistry Biodiversity. 2010; 7(2): 415-420.

60. Scalzo LR, Picchi V, Migliori AC, Campanellli G, Leteo F, Ferrari V and Di Cesare F. L. Variations in the phytochemical contents and antioxidant capacity of organically and conventionally grown Italian cauliflower (Brassica oleracea L. subsp. botrytis): Results from a three-year field study. Journal of Agricultural and Food Chemistry. 2013; 61: 43. 10335-10344.

61. Filman DJ, Brawn RJ and Dandliker WB. Intracellular supravital stain delocalization as an assay for antibody-dependent complement-mediated cell damage. Journal of Immunological Methods. 1975; 6(3): 189-207.

62. Borenfreund E and Puerner JA. A simple quantitative procedure using monolayer cultures for cytotoxicity assay (HTDM 90). Journal of Tissue Culture Methods. 1984; 9: 7-9.

63. Cheng Y-C and Prusoff WH. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochemical Pharmacology. 1973; 22: 3099-3108.

64. Huang MC, Ashmun RA, Avery TL, Kuehl M and Blakley RL. Effects of cytotoxicity of 2-chloro-2’-deoxyadenosine and 2-bromo-2’-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics. Cancer Research. 1986; 46: 2362-2368.

65. Neubig RR, Spedding M, Kenakin T, Christopoulos A and International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification, XXXVIII-Update on terms and symbols in quantitative pharmacology. Phamacological Reviews. 2003; 55: 597-606.

66. Yifeng H, Qiujing Z, Mo C, Qihong H, Wenjing W, Qing L, Yuting H and Wen D. The changing 50% inhibitory concentration (IC50) of cisplatin: a pilot study on the artifacts of the MTT assay and the precise measurement of density-dependent chemoresistance in ovarian cancer. Oncotarget. 2016; 7(43): 70803-70821.

67. Akbari R and Javar AH. Efficacy of Capecitabine and 5-Fluorouracil (5-FU) on the human breast cancer cell line (MCF7) – effect of concentration. American Journal of Research Communication. 2013; 1(6): 75-91.

68. Onyancha JM, Gikonyo NK, Wachira SW, Mwitari PG and Gicheru MM. Anticancer activities and safety evaluation of selected Kenyan plant extracts against breast cancer cell lines. Journal of Pharmacognosy and Phytotherapy. 2018; 10(2): 21-26.

69. Hector H-V, Esteban B, Pedro C-S, Cayetano von K, Inmaculada B-R, Manel E, Gema M-B and Jose P. Transcriptional profiling of MCF-7 breast cancer cells in response to 5-Fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. International Journal of Cancer. 2006; 119(5): 1164-75.

70. Abdul-Hameed ES, Salih A, Bazaid SA, Shohayeb MM, El-Sayed MM and El-Wakil EA. Phytochemical studies and evaluation of antioxidant, anticancer and antimicrobial properties of Conocarpus erectus L. growing in Taif, Saudi Arabia. European Journal of Medicinal Plants. 2012; 2: 93-112.

71. Sajjadi SE, Ghanadian M, Haghighi M and Mouhebat L. Cytotoxic effect of Cousiniaver bascifolia bunge against OVCAR-3 and HT-29 cancer cell. Journal of HerbMed Pharmocology. 2015; 4(1): 15-19.

72. Grem JL. 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development. Investigation New Drug. 2000; 18: 299-313.

73. Osterlund P, Ruotsalainen T, Peuhkuri K, Ollus A, Ikonen M, Joensuu H and Elomaa. Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer. Clinical Gastroenterology and Hepatology. 2004; 2(8): 696-703.

74. Srivastava S, Mohammad S, Gupta S, Mahdi AA, Dixit R, Singh V and Samadi MF. Chemoprotective effect of nanocurcumin on 5-fluorouracil-induced-toxicity toward oral cancer treatment. National Journal of Maxillofacial Surgery. 2018; 24(3): 274-288.

75. Macdonald JS. Toxicity of 5-fluorouracil. Oncology. 1999; 13(7 Suppl 3): 33-34.

76. Rexroth G and Scotland V. Cardiac toxicity of 5-fluorouracil. Medizinische Klinik. 1994; 89(12): 680-688.

77. Rastogi N, Chag M and Ayyagari S. Myocardial ischemia after 5-flurouracil chemotherapy. International Journal of Cardiology. 1993; 42(3): 285-287.

78. Yusefi M, Shameli K, Jahangirian H, Teow S-Y, Umakoshi H, Saleh B, Rafiee- Moghaddam R and Webster JT. The potential anticancer activity of 5-fluorouracil loaded in cellulose fibres isolated from rice straw. International Journal of Nanomedicine. 2020; 15: 5417-5432.